chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: HEP, HEPA, IPV, MNQ, TDAP
Symptoms: Dizziness, Eye pain, Headache
Clinical narrative: Case number PHHY2014US152414 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 540636) website o n13 NOV 2014. This report refers to an 18 years old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with MENVEO (batch number: M13053) and IPOL (other manufacturer, batch number: K11692); both vaccines administered intramuscularly in the left arm on 11 AUG 2014. On the same day, she also received BOOSTRIX (other manufacturer, batch number: 37S2B), HAVRIX (other manufacturer, batch number: 9K22D) and ENGERIX-B (other manufacturer, batch number: AHBVC263AA), all vaccines administered intramuscularly in the right arm and MMR II (other manufacturer, batch number: J008153) subcutaneously in the left arm. On 12 AUG 2014, she experienced lightheadedness (dizziness), headache and her eye muscles were hurting. The final outcome was not reported. The events were reported as non-serious. The causality of the event was not reported.
Age: 17.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site nodule, Injection site swelling
Clinical narrative: Case number PHHY2014US153114, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540711) website on 13 NOV 2014. This report refers to a 17-year-old female patient. Medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14022) intramuscularly and VARIVAX (batch number: K002912) subcutaneously both into left arm on 19 AUG 2014. On the same day, after vaccination, she developed redness, swelling and hard knot at the injection site. Redness and swelling at the injection site increased at the time of this report. Final outcome of the events was reported as unknown. These events were reported as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MEN, TDAP
Symptoms: Erythema, Injection site induration, Injection site nodule, Peripheral swelling, Pruritus
Clinical narrative: Case number PHHY2014US145155 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 540716) on 28 Oct 2014. This report refers to an 11 years old male patient. His medical history was not reported and concomitant medications included unspecified nasal spray, DYMISTA and antihistamine for adenoid hypertrophy. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported) in the right arm on 19 Aug 2014. On the same day he also received Tdap (manufacturer and batch number: not reported) in the left arm. On the same day the left arm started with swelling, bright red circle, hot to touch, itch and there was a hard knot at the location of injection. It reached the size of quarter by 20 Aug 2014 and expanded to the size of adult hand. On 20 Aug 2014, the right arm started with the same symptoms. He was treated with BENADRYL ointment on both sites and he received BENADRYL oral at bed time on 20 Aug 2014. He also kept ice packs and warm compresses on and off throughout the day. The events in right arm were of the size of 1/2 dollar on 21 Aug 2014. The event outcome was not reported. The events were reported as non-serious. The causality was not reported.
Age: 11.0
Sex: M
Vaccine: MEN, TDAP
Symptoms: Skin warm
Clinical narrative: Case number PHHY2014US145155 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 540716) on 28 Oct 2014. This report refers to an 11 years old male patient. His medical history was not reported and concomitant medications included unspecified nasal spray, DYMISTA and antihistamine for adenoid hypertrophy. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported) in the right arm on 19 Aug 2014. On the same day he also received Tdap (manufacturer and batch number: not reported) in the left arm. On the same day the left arm started with swelling, bright red circle, hot to touch, itch and there was a hard knot at the location of injection. It reached the size of quarter by 20 Aug 2014 and expanded to the size of adult hand. On 20 Aug 2014, the right arm started with the same symptoms. He was treated with BENADRYL ointment on both sites and he received BENADRYL oral at bed time on 20 Aug 2014. He also kept ice packs and warm compresses on and off throughout the day. The events in right arm were of the size of 1/2 dollar on 21 Aug 2014. The event outcome was not reported. The events were reported as non-serious. The causality was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2014US153174, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540780) website on 13 NOV 2014. This report refers to an 11-year-old female patient. Concomitant condition included allergy to pet dander. Historical drug include Omnicef. She was vaccinated with MENVEO (batch number: M14031) intramuscularly into right arm on 19 AUG 2014. On the same day she concomitantly vaccinated with ZOSTAVAX (batch number: D93LR, other manufacturer) into left arm intramuscularly. On the same day, after vaccination, she experienced mild redness and swelling of the area of 8cm x 8cm at the injection site of right arm. She went to emergency room due to these events. Outcome of the events ws reported as unknown. These events were reported as non-serious. Causality of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Extensive swelling of vaccinated limb, Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: Case number PHHY2014US145149 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 540794) on 28 OCT 2014. This report refers to an 11 years old male patient. His medical history was not reported and concomitant medications included  escitalopram 15 mg and melatonin 1 mg in the night. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported) in the left arm on 14 JUL 2014. On the same day within thirty minutes, there was an inch wide ring around the site. Within 6 hours, the redness increased to 2 inches in diameter. On 15 JUL 2014 morning, the diameter was 4 inches and redness deepened. By 3 PM that day, the site was an angry red, 6 inches in diameter. On 15 JUL 2014 morning, the diameter was 4 inches and redness deepened. By 3 PM that day, the site ws an angry red, 6 inches in diameter, raised, hardened and itchy. On 16 JUL 2014 and 17 JUL 2014 (third and fourth days after vaccination), it covered his entire upper shoulder and was approximately 8 inches in diameter. He went to emergency room. The redness, itching and swelling gradually subsided, but it took almost two weeks. The event outcome was reported as complete recovery. The events were reported as non-serious. The causality was not reported.
Age: 18.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: No adverse event, Wrong technique in product usage process
Clinical narrative: Case number PHHY2014US153172, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540848) website on 13 NOV 2014. This report refers to an 18 year old female patient. Her medical history and concomitant medication were not reported. On 14 AUG 2014, she was inadvertently vaccinated only with the powder component of MENVEO. (batch number: 14023) intramuscularly in left arm., She ws concomitantly vaccinated with RECOMBIVAX HB (other manufacturer, batch number: J006511) intramuscularly in right arm on 14 AUG 2014. No adverse event was reported following this administration error (inappropriate preparation of medication).
Sex: U
Vaccine: HPV4, MNQ, TDAP
Symptoms: No adverse event, Wrong technique in product usage process
Clinical narrative: Case number PHHY2014US153187, is an initial spontaneous report from Vaccine Adverse Event Reporting System (VAERS, reference number: 540850) website on 13 NOV 2014. This report refers to a patient of unknown demographics. Historical condition was not reported. Concomitant vaccination included ADACEL (other manufacturer, batch number: U4639AA) intramuscularly in left arm and GARDASIL (other manufacturer, batch number: K003520) intramuscularly in right arm on 14 AUG 2014. On 14 AUG 2014, the patient was inadvertently vaccinated only with the powder component of MENVEO (batch number: M14023) intramuscularly in right arm. No adverse event was reported following the administration error (inappropriate preparation of medication).
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site paraesthesia, Injection site swelling
Clinical narrative: Case number PHHY2014US153232, is an initial spontaneous report received from the vaccine Adverse Event Reporting System (VAERS reference number: 540879) website on 13 NOV 2014. This report refers to an 11-year-old male patient. Concurrent conditions included attention deficit hyperactivity disorder (ADHD), anxiety, decreased hearing and learning difficulty. Concomitant medication included alprazolam. He was vaccinated with MENVEO (batch number: M14023) along with ADACEL (batch number: C4506BA,m other manufacturer) intramuscularly into left arm on 18 AUG 2014. On 20 AUG 2014, the patient experienced throbbing pain, tingling, redness and swelling at the injection site. The patient was treated with Benadryl and Claritin. Outcome of the events was reported as unknown. These events were reported as non-serious. Causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HEPA, MEN, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Case number PHHY2014US144359 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 540891) website on 28 Oct 2014. This report refers to a 12 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported) in the left arm, hepatitis A vaccine (other manufacturer, batch number: not reported) in the right arm, Tdap (other manufacturer, batch number: not reported) intramuscularly in the right arm and with unspecified vaccines intramuscularly in the left arm; all vaccines administered on 22 Aug 2014. On 22 Aug 2014, his site of shot was hard and swollen and the areas was very red and hot. A line was drawn around the border of swelling and it was about the size of a quarter. At noon on 23 Aug 2014, vaccination area was checked again and it had some more swelling. it was reported that another border line was marked around the swelling. He had ice pack applied to area for 15 minutes and swelling appeared to decrease. The site was checked again at 9 pm and there was no change. At noon on 24 Aug 2014, the site was checked again. It was reported that swelling had increased again and was found to be 3 inches in diameter. Site was extremely hot, red and hard. He was treated with ibuprofen 200mg and Benadryl 25mg. Fever was checked and his body temperature was at 100.2 orally. He had ice applied for 15 minutes and the site was rechecked at 3:30 pm. It was found that swelling had decreased and fever had come down to 99.2. The events were monitored and it appeared to be getting better till at 9 pm. The final outcome was reported as complete recovery. The even was reported non-serious. The causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Rash, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Case number PHHY2014US153690 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 541019) website on 13 NOV 2014. This report refers to an 11 years old female patient. Her medical history included Attention Deficit Hyperactivity Disorder (ADHD). Her current condition included allergy and asthma. her concomitant medications were unspecified medications used for allergy and asthma. She was vaccinated with MENVEO (batch number: M14023) in the right arm and BOOSTRIX (other manufacturer, batch number: D93LR) in the left arm; both vaccines administered on 18 AUG 2014. On 20 AUG 2014, about 40 hours after immunization, her right deltoid (vaccinated site) became erythematous, swollen and warm. The site was not pruritic or painful and there was no decreased range of motion. She also experienced rash on 20 AUG 2014. She saw doctor on 20 AUG 2014 and she had no treatment. Rash resolved within 48 hours. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 18.0
Sex: M
Vaccine: MNQ, TD, TYP, VARCEL
Symptoms: Abdominal discomfort, Abdominal pain upper, Nausea, White blood cell count normal
Clinical narrative: Case number PHHY2014US154118 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 541020) website on 13 NOV 2014. This report refers to an 18 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number M13050) intramuscularly in the left arm, TENIVAC (other manufacturer, batch number: U4606AB) intramuscularly in the right arm, VIVOTIF (other manufacturer, batch number: 3000843) via oral route and VARIVAX (other manufacturer, batch number: J012371) (subcutaneously in the right arm; all vaccines administered on 12 AUG 2014. On 12 AUG 2014, evening he experienced slight stomach upset. He had second does of ViVOTIF (batch number: not reported) on an unknown date in AUG 2014 following which he had more stomach cramping and nausea. With third dose of VIVOTIF (batch number: not reported) he again had severe cramping and nausea in AUG 2014. he went to emergency room and had his blood work done and his white blood cell count was within normal limits. He took the fourth dose of VIVOTIF (batch number: not reported) in AUG 2014 and stated that he did better with the last dose as he had only slight stomach upset when comparable to the first dose. He felt fine on the day of reporting with  no symptoms. He was advised to take injectable typhoid vaccine in future. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 19.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Computerised tomogram head normal, Feeling abnormal, Headache
Clinical narrative: Case number PHHY2014US154377 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 541033) website on 13 NOV 2014. This report refers to a 19 years old male patient. His medical history and concomitant medication were not reported. His vaccination history included administration of tetanus vaccine (manufacturer and batch number: not reported) 5 years ago and the vaccine was well tolerated. He was vaccinated with MENVEO (batch number: A1403) in the left arm and BOOSTRIX (other manufacturer, batch number: 5TN9R) in the righ arm, both vaccines given on 01 AUG 2014. On the same day he developed headache and felt like he was in fog. Headache was across frontal region. He took ibuprofen, but it did not help symptoms. He went to emergency room and Computerized Tomogram (CT) scan of head was done and it was normal. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Urticaria
Clinical narrative: Case number PHHY2014US154410, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 541161) website on 13 NOV 2014. This report refers to a 12 year old male patient. His historical condition and concomitant medication were none. He was vaccinated with MENVEO (batch number: M14030) intramuscularly in left leg, VAQTA (other manufacturer, batch number: K000943) intramuscularly in right leg, GARDASIL (other manufacturer, batch number: J015378) intramuscularly in right leg; BOOSTRIX (other manufacturer, batch number: 7GH57) intramuscularly in right leg and VARIVAX (other manufacturer, batch number: K002920) subcutaneously in left leg on 20 AUG 2014. On the same day, approximately 1 hour after vaccination, he developed hives. He was taken to emergency room. Final outcome was unknown. The event was reported as non-serious. Causality was not reported.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Mass
Clinical narrative: Case number PHHY2014US153856, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 541170) website on 13 NOV 2014. This report refers to a 12 year old female patient. Historical condition was not reported. No concomitant medication was reported. She was vaccinated with MENVEO (batch number: 14021) intramuscularly in left arm and ADACEL (other manufacturer, batch number: U4853AA) intramuscularly in right arm on 24 JUL 2014. On 25 JUL 2014, following vaccinations, she developed a lump at arm (specific arm was not clear). Final outcome was complete recovery. The event was reported as non-serious. Causality was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Inflammation, Rash
Clinical narrative: Case number PHHY2014US154394, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 541236) website on 13 NOV 2014. This report refers to an 11 year old male patient. His historical condition and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: M14025) and BOOSTRIX (other manufacturer, batch number: 54MX9) both intramuscularly in left arm on 26 AUG 2014. On the same day after vaccination, he developed small rash and inflammation on left arm but no fever. Final outcome was unknown. These events were reported as non-serious. Causality was not reported.
Age: 60.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Case number PHHY2014US154901, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 541241) website on 13 NOV 2014. This report refers to a 60 year old male patient. His historical conditions and concomitant medication were not reported. It was reported that instead of MENACTRA (other manufacturer), he was vaccinated with MENVEO (batch number: 12127) intramuscularly in right arm on 17 OCT 2013. No adverse event was reported following this administration error (wrong drug administered)
Age: 60.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Medication error, No adverse event
Clinical narrative: Case number PHHY2014US154901, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 541241) website on 13 NOV 2014. This report refers to a 60 year old male patient. His historical conditions and concomitant medication were not reported. It was reported that instead of MENACTRA (other manufacturer), he was vaccinated with MENVEO (batch number: 12127) intramuscularly in right arm on 17 OCT 2013. No adverse event was reported following this administration error (wrong drug administered)
Age: 59.0
Sex: F
Vaccine: MNQ, MNQ, MNQ
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Case number PHHY2014US154919, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 541241) website on 13 NOV 2014. This report refers to a 59 year old female patient. Her historical condition and concomitant medication were not reported. It was reported that instead of MENACTRA (other manufacturer) she was vaccine with MENVEO (batch number: 12127) intramuscularly in right arm on 17 OCT 2013. No adverse event was reported following this administration error (wrong drug administered)
Age: 59.0
Sex: F
Vaccine: MNQ, MNQ, MNQ
Symptoms: Medication error, No adverse event
Clinical narrative: Case number PHHY2014US154919, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 541241) website on 13 NOV 2014. This report refers to a 59 year old female patient. Her historical condition and concomitant medication were not reported. It was reported that instead of MENACTRA (other manufacturer) she was vaccine with MENVEO (batch number: 12127) intramuscularly in right arm on 17 OCT 2013. No adverse event was reported following this administration error (wrong drug administered)
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US154060, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 541403) website on 13 NOV 2014. This report refers to an 11-year-old male patient. Historical conditions and current illness were none. No concomitant mediation was reported. He was vaccinated with MENVEO (batch number: A14031) intramuscularly into the left arm on 26 AUG 2014. On the same day after vaccination, the patient developed redness, tenderness, warm to touch and her entire upper arm was swollen. The outcome of the events was complete recovery. The events were reported as non-serious. Causality was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Crying, Dizziness, Hypotension
Clinical narrative: Case number PHHY2014US153104, is an initial spontaneous report received from the vaccine Adverse Event Reporting System (VAERS reference number: 541496) website on 13 NOV 2014. This report refers to an 11 year old female patient. She had no medical history or current condition. Concomitant medication was not reported. On 19 AUG 2014, she was vaccinated with MENVEO (other manufacturer, batch number: J006850) intramuscularly in right arm and BOOSTRIX (batch number: A54AL) intramuscularly in left arm. On the same day after vaccination , she began to cry. She felt dizzy as she was crying. The patient was laid down on a table for 05 minutes. She began to feel better. Her blood pressure (BP) was 99/66 while lying down. The patient sat up and her BP was 108/71. She stood up and felt good to walk. Her BP was 111/56.  Patient was allowed to leave. Her mother was advised to lay her down in case of further dizziness or visit emergency room if dizziness persisted. Final outcome was complete recovery. These events were reported as non-serious. Causality was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2014US154157, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 541558) website on 13 NOV 2014. This report refers to an 11-year-old male patient. Concurrent conditions included asthma. Concomitant medications included Symbicort and Xopenex. He was vaccinated with MENVEO (batch number: A14041) intramuscularly on 26 AUG 2014. On 27 AUG 2014, the patient injection site became very swollen and painful. The patient tried Benadryl and IBU without relief. The final outcome of the events was unknown. The events were reported as non-serious. Causality was not reported.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site scab, Injection site warmth
Clinical narrative: Case number PHHY2014US155338 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 541956) website on 13 NOV 2014. This report refers to a 16 year old male patient. His past medical history and concomitant medications were not reported. On 26 AUG 2014, he was vaccinated with MENVEO (batch number: M14041) into his left deltoid. On 27 AUG 2014, his left deltoid area was minimally erythematous and indurated. It was not warm to touch but had scabbed entry point of the needle as the patient picked it. It was reported as a topical local reaction only. The patient completely recovered from the events on an unspecified date. The events were reported as non serious and the causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US155343 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 541973) website on 13 NOV 2014. The report refers to a 11 year old male patient. His past medical history and concomitant medications were not reported. On 19 AUG 2014, he was vaccinated with MENVEO (batch number: M14023) into his left arm and with VARIVAX (other manufacturer, batch number: K002045) subcutaneously into his left arm. On 20 AUG 2014, he had large local reactions characterized by warmth swelling and redness around both sites. The outcome of the events was unknown. The events were reported as non serious and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US155348 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 541976) website on 13 NOV 2014. This report refers to an 11 year old male patient. His past medical history and concomitant medications were not reported. On 19 AUG 2014, he was vaccinated with MENVEO (batch number: M14023) into his left arm and with VARIVAX (other manufacturer, batch number: K002042) subcutaneously into his left arm. On 20 AUG 2014, he had large local reactions characterized by warmth, swelling and redness around both sites. The outcome of the events was unknown. The events were reported as non serious and causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Crying, Dyskinesia, Hypotension, Nausea, Skin discolouration
Clinical narrative: Case number PHHY2014US169351 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 542260) on 29 DEC 2014. This report refers to a 112 years old male patient. Past medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M14023) and GARDASIL (other manufacturer, batch number: J013324), both vaccines administered in the left arm on 18 AUG 2014. He also received HAVRIX (other manufacturer, batch number: 5324E) and BOOSTRIX (other manufacturer, batch number: A54AL); both vaccines administered in the right arm on the same date. On 18 AUG 2014, approximately 10 minutes after vaccination, he saw that his brother had jerking movement with injection. After seeing his brother, he felt nausea and he became white in color. He was crying and he sat on chair. His blood pressure was 102/60 (units and normal values were not reported). He had cool compress. After seeing his brother was okay, he walked to the car. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported. Following an internal review on 31 DEC 2015 of the date received on 20 DEC 2014, it was identified that the event verbatim "he was shite in color" was erroneously  coded as pale and hence the event was now recoded as skin discoloration.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site swelling, Pruritus, Vaccination site warmth
Clinical narrative: Case number PHHY2014US170813, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 542261) website on 29 DEC 2014. This report refers to a 11-year-old male patient. On 05 AUG 2014, he was vaccinated with MENVEO (batch number: M14021) and BOOSTRIX (other manufacturer, batch number: N2K27), in the left arm. On 06 AUG 2014, his arm muscle where vaccinations were given was swelled and hot to touch. He also had itchiness (site unspecified). The patient visited the emergency room. The patient received antibiotic Celaxin. On 11 AUG 2014, the patient's father stated that the swelling was down,  no more pain but had itchiness. The final outcome of the events reported as recovered. The events reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site vesicles
Clinical narrative: Case number PHHY2014US170824, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 542384) website on 29 DEC 2014. This report refers to a 11-year-old male patient. His current condition included known SVT (supraventricular tachycardia) and he had no know allergies. Concomitant drug included atenolol. He was vaccinated with  MENVEO (batch number: A14044) intramuscularly in the left arm on 27 AUG 2014. On the same date, after vaccination, he experienced localized reaction to left arm extending from shoulder to two inches above elbow which was reported as firm, indurated, erythematous skin with quarter sized area vesicles at site of injection. The final outcome of the events reported as recovered. The events reported as non-serious. The causality of the events was not reported.
Age: 22.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2014US154969, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 542680) on 13 NOV 2014. This report refers to a 22 years old female patient. Her medical history and concomitant medications were not reported. She as vaccinated with MENVEO (batch number: M14044) intramuscularly in the left arm on 04 SEP 2014. She as also vaccinated with ADACEL (other manufacturer, batch number: U4689CA) intramuscularly in right arm on 04 SEP 2014. It was reported that o 05 SEP 2014 she woke up feeling feverish. She was treated with TYLENOL and advised to take rest. The outcome of the event was reported as unknown. The health authority reported that the event was non-serious and causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Cold sweat, Dizziness, Pallor, Skin warm
Clinical narrative: Case number PHHY2014US170756 is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS ID: 542772) on 29 DEC 2014. This report refers to an 11 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch  number: M14031) intramuscularly in the right arm on 26 AUG 2014. On the same date, she also received BOOSTRIX (other manufacturer, batch number: LF444) intramuscularly in the right arm and GARDASIL (other manufacturer, batch number: J006850) intramuscularly in the left arm. On 26 AUG 2014, after vaccination, she was dizzy, pale, clammy and warm. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Case number PHHY2014US170856 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 542802) on 29 DEC 2014. This report refers to an 11 years old male patient. His medical history included Reaction Attachment Disorder (RAD) and current conditions included attention deficit hyperactivity disorder (ADHD) and learning disability. His concomitant medications were Concerta and Singulair. He was vaccinated with MENVEO (other manufacturer, batch number: A14021) in the left leg and BOOSTRIX (other manufacturer, batch number: J4N25) in the righ leg; both vaccines administered on 26 AUG 2014, he had a red area measuring 6.25 inches by 7.5 inches which was hot to touch and swollen. He had no difficulty in breathing or swallowing. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 37.0
Sex: M
Vaccine: MNQ
Symptoms: Axillary mass, Pyrexia
Clinical narrative: Case number PHHY2014US154924, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 542854) website on 13 NOV 2014. This report refers to a 37-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient had no known drug allergies. He was vaccinated with MENVEO (batch number: M14031) intramuscularly on 05 SEP 2014. On 06 SEP 2014, the patient developed fever and lump under the left arm pit. The outcome of the events was unknown. The events were reported as non-serious. Causality was not reported. The patient was advised to have provider further evaluate situation.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site swelling
Clinical narrative: Case number PHHY2014US171325 is an initial spontaneous report received from a consumer via the Vaccine Adverse Event Reporting System (VAERS ID: 542994) website on 29 DEC 2014. This report refers to an 11 year old female patient. Her past medical history and concomitant medications  were not reported. On 04 AUG 2014, she was vaccinated with MENVEO (batch number: M13030) into her right deltoid and with ADACEL (batch number: U4684BA) into her right deltoid. On 05 AUG 2014, she had swelling of deltoid area uniformly formed with no isolated mass. The final outcome of the event was complete recovery. The event was reported as non serious and causality of the event was not reported.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Injection site rash
Clinical narrative: Case number PHHY2014US170794, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 543001) website on 29 DEC 2014. This report refers to a 17-year-old female patient. Concurrent conditions included abdomen pain and obsessive-compulsive disorder (OCD). She had no allergies. On 31 JUL 2014, she was vaccinated with MENVEO (batch number: A14031) intramuscularly and VARIVAX (batch number: J012377, other manufacturer) subcutaneously , both vaccines into right arm. On the same day she was concomitantly vaccinated with HAVRIX (batch number: 572L4, other manufacturer) and GARDASIL (other manufacturer, batch number: K003520), both vaccines intramuscularly into left arm. On an unknown date after vaccinations, she experienced rash on right upper arm. Outcome of the event was recovered. The case was assessed as non-serious. causality of the event was not reported.
Age: 38.0
Sex: F
Vaccine: HEPAB, MMR, MNQ
Symptoms: Chills, Headache, Nausea, Neck pain, Pyrexia
Clinical narrative: Case number PHHY2014US155045, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540070) website on 13 NOV 2014. This report refers to a 38-year-old female patient. Concurrent conditios included urinary frequency, left leg pain at knee and right hand numbness with shoulder pain and hypertension. Concomitant medications included Medrol. She was vaccinated with MENVO (batch number: A13047) along with TWINRIX (batch number: 5JRTT) and MMR II (batch number: 5JRTT) on 04 SEP 2014. On 05 SEP 2014, the patient experienced nausea, headache, fever, chills and neck pain. The outcome of the events was unknown. The events were reported as non-serious. Causality was not reported.
Age: 16.0
Sex: M
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Body temperature increased, Injection site hypoaesthesia, Injection site pain, Injection site papule, Injection site swelling
Clinical narrative: Case number PHHY2014US170796, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 543189) website on 20 DEC 2014. This report refers to a 16-year-old male patient. Concurrent conditions included hypertension, probably sexually transmitted disease (STD), attention deficit/hyperactivity disorder (ADHD) and depression. He had no known allergies. Concomitant medication included azithromycin. On 08 SEP 2014, he was vaccinated with MENVEO (batch number: M13015) intramuscularly into left arm. On the same day, he was also vaccinated with VARIVAX (batch number: K001389, other manufacturer) subcutaneously into right arm, HAVRIX (batch number: J012212) intramuscularly into left arm and GARDASIL (other manufacturer, batch number: J012212) intramuscularly into right arm. On 09 SEP 2014, he experienced pain, swelling, numbness and papules at right upper arm. He had a low grade body temperature of 100.1 degrees. It was reported that he was able to move his arm. Outcome of the events was recovered. The case was assessed as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: FLUN4, HEPA, HPV4, MNQ
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US153657 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 543285) on 13 Nov 2014. This report refers to an 11 year old male patient. His past medical history included allergic rhinitis and concomitant medications included fluticasone nasal spray. On 08 Sep 2014, he was vaccinated with MENVEO (batch number: M1402L) intramuscularly into her right arm, with HAVRIX (batch number: A7HC5) intramuscularly into his left arm, with GARDASIL (other manufacturer, batch  number: K001500) intramuscularly into his left arm and with FLUMIST (other remanufacturer, batch number: CF2182). On 09 Sep 2014, the patient's mother noticed a large hot swelling at the injection site on the right arm measuring 8 cm X 8 cm. The patient completely recovered from the events on an unspecified date. The events were reported as non serious and causality of the events was not reported.
Age: 16.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site oedema, Vaccination site warmth
Clinical narrative: Case number PHHY2014US170797, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 543342) website on 29 DEC 2014. This report refers to a 16-year-old female patient. Medical history included shingles. Concomitant medications included unspecified medications for birth control. On 03 SEP 2014, she was vaccinated with MENVEO (batch number: M13014) into right arm. On the same day, she was also vaccinated with GARDASIL (batch number: K004546, other manufacturer) into right arm, BOOSTRIX (batch number: K004546, other manufacturer) into left arm and VARIVAX (batch number: K002914, other manufacturer) into left arm. On 09 SEP 2014, she experienced redness (3 inches), edema (8 mm), itchy and hot to touch at vaccination site. Outcome of the events was unknown. The case was assessed as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Injection site discomfort, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US155358 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 543602) website on 13 Nov 2014. This report refers to an 11 year old male patient. On 22 Sep 2010, a blood allergy test was performed and the patient was responsive to cashew nut, sesame seed, walnut, horse dander, dust mites, trees/pollen, dog dander and mold. His current conditions included allergic rhinitis and his past medical history included allergic conjunctivitis and eczema. His concomitant medications included Fluticasone. On 11 Sep 2014, he was vaccinated with MENVEO (batch number: A14044) intramuscularly into his left arm. On 11 Sep 2014, he noted discomfort, redness and warmth of his left arm (site of injection) about an hour after vaccine administration. When the patient woke up on 12 Sep 2014, he complained of further discomfort and his father noted arm to be swollen, warm and red extending near area from deltoid to forearm. Patient was seen on 12 Sep 2014 at clinic for evaluation. The outcome of the events was unknown. The events were reported as non serious and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2014US155358 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 543602) website on 13 Nov 2014. This report refers to an 11 year old male patient. On 22 Sep 2010, a blood allergy test was performed and the patient was responsive to cashew nut, sesame seed, walnut, horse dander, dust mites, trees/pollen, dog dander and mold. His current conditions included allergic rhinitis and his past medical history included allergic conjunctivitis and eczema. His concomitant medications included Fluticasone. On 11 Sep 2014, he was vaccinated with MENVEO (batch number: A14044) intramuscularly into his left arm. On 11 Sep 2014, he noted discomfort, redness and warmth of his left arm (site of injection) about an hour after vaccine administration. When the patient woke up on 12 Sep 2014, he complained of further discomfort and his father noted arm to be swollen, warm and red extending near area from deltoid to forearm. Patient was seen on 12 Sep 2014 at clinic for evaluation. The outcome of the events was unknown. The events were reported as non serious and causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Erythema, Feeling abnormal, Oedema peripheral, Skin warm
Clinical narrative: Case number PHHY2014US154549, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 543635) website on 13 Nov 2014. This report refers to an 11 year old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: M13015) into right arm on 05 May 2014. On the same day she also received GARDASIL (batch number: H021608, other manufacturer) into left arm and BOOSTRIX (batch number: AC52B088AA, other manufacturer) into right arm. On the same day post vaccination her right arm was reddish and warm to the touch, an edema. She also felt tickling all over the right arm. She went to the emergency room.  Outcome of the events was completely recovered. Events were reported as non-serious. Causality assessment was not reported.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US170798, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 543706) website on 29 Dec 2014. This report refers to a 16-year-old female patient. Medical history and concomitant medications were not reported. On 11 Sep 2014, she was vaccinated with MENVEO (batch number: A14021) into left arm. On 12 Sep 2014, the patient experienced swelling, pain, redness and warm at left deltoid. The patient was treated with Benadryl, ibuprofen and cool compress. Outcome of the events was unknown. The case was assessed as non-serious. Causality of the events was not reported.
Age: 24.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site rash, Injection site warmth, Pain in extremity
Clinical narrative: Case number PHHY2014US170913, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 543721) website on 29 Dec 2014. This report refers to a 24-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with MENVEO (batch number: A14041) intramuscularly on 05 Sep 2014. On 08 Sep 2014, she experienced rash starting about one to two inches below injection site and it was warm. The rash was spreading down the arms towards the elbow. The patient's arm was hurting. The final outcome of the events was unknown. The events were reported as non-serious. Causality was not reported.
Age: 16.0
Sex: M
Vaccine: HEP, HEPA, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Pruritus, Rash maculo-papular, Skin lesion
Clinical narrative: Case number PHHY2014US169330 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543794) on 29 Dec 2014. This report refers to a 16 years old male patient. He denied past medical history or current illness. There were no concomitant medications. On 10 Sep 2014, he was vaccinated with MENVEO (batch number: A13053) and HAVRIX (other manufacturer, batch number: 5954N); both vaccines administered intramuscularly in the right arm, ENGERIX B (other manufacturer, batch number 9423K) and BOOSTRIX (other manufacturer, batch number: 47287); both vaccines administered intramuscularly in the left arm. He also received MMR II (other manufacturer, batch number: J007930) and VARIVAX (other manufacturer, batch number: J012375); both vaccines administered subcutaneously in the right arm and IPOL (other manufacturer, batch number: J1731) subcutaneously in the left arm on 10 Sep 2014. On 12 Sep 2014, he complained of onset of rash which was maculopapular. The lesions were present on left arm, concentrated near exterior side of left elbow and left forearm. There were 2 to 3 lesions each on ankles, neck, left mid abdomen and upper back. he also complained of itching. He presented to the health department on 15 Sep 2014. He denied any fever, chills, fatigue, malaise, sore throat, cough or other prodromal type symptoms. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 16.0
Sex: M
Vaccine: FLU3, HPV4, MNQ
Symptoms: Injection site hypoaesthesia, Injection site swelling, Muscular weakness
Clinical narrative: Case number PHHY2014US171048 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543820) on 29 Dec 2014. This report refers to a 16 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M14041) intramuscularly in the right arm on 10 Sep 2014. He also received FLUZONE (other manufacturer, batch number: UI191AA) intramuscularly in the left arm and GARDASIL (other manufacturer, batch number: K001631) intramuscularly in the right arm on the same date. On 11 Sep 2014, he experienced right arm injection site numbness (no numbness in rest of the arm). He also had weakness of arm and mild swelling in site. The swelling improved later. The outcome of swelling was reported as condition improving and that of other events were reported as condition unchanged. The events were reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Headache, Pyrexia
Clinical narrative: Case number PHHY2014US171262 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543821) on 29 Dec 2014. This report refers to an 11 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A14023) and BOOSTRIX (other manufacturer, batch number: 4JL44); both vaccines administered in the left arm on 20 Aug 2014. On 06 Sep 2014, he experienced fever which prolonged for 7 days. He also had headache. He went to emergency room twice. It was not sure whether the patient experienced a viral infection or vaccination reaction. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.